Lubomir Vezenkov

4PUBLICATIONS
18CO-AUTHORS
Predictive and prognostic markersMolecular targetsCharacterisation of biological macromoleculesProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 31, 2025
Peptide-based covalent inhibitor of tubulin detyrosination promotes mesenchymal-to-epithelial transition in lung cancer cells.

Hathaichanok Impheng, Ghislain Gillard, Nuttanid Numnoi

|Nov 13, 2025
Real-time FRET assay for monitoring detyrosination by TMCP1 and VASH2.

Matthieu Simon, Julien Espeut, François Juge

|Aug 25, 2025
Development of Low-Nanomolar Covalent Epoxide Inhibitors of Tubulin Detyrosinating Enzymes VASH1&2.

Anthony Feral, Guillaume Marcellin, Yoann Lannay

|Jun 17, 2023
Covalent-reversible peptide-based protease inhibitors. Design, synthesis, and clinical success stories.

Anthony Feral, Anthony R Martin, Alexandre Desfoux

Pageof 1

Frequent Collaborators

4 joint publications

Muriel Amblard

3 joint publications

Anthony Feral

3 joint publications

Krzysztof Rogowski

2 joint publications

Matthieu Simon